DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹34 Cr | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr |
What is the latest Long Term Provisions ratio of DR REDDYS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹34 Cr |
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹26 Cr |
How is Long Term Provisions of DR REDDYS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹34 Cr | 13.42 | |
| Mar2025 | ₹30 Cr | 24.69 | |
| Mar2024 | ₹24 Cr | 20.10 | |
| Mar2023 | ₹20 Cr | -22.87 | |
| Mar2022 | ₹26 Cr | - | |
Compare Long Term Provisions of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹96,324.4 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| MANKIND PHARMA | ₹96,179.6 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.9% |
-1.8% |
-9.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses